Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HongYuanDa oral iron versus intravenous iron sucrose in maintenance hemodialysis patients
ChiCTR2000031166Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Apr 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of iron polysaccharide complex and iron sucrose in iron deficiency anemia (IDA) and chronic kidney disease (CKD) (2 arms), sponsored by Renji Hospital. Primary endpoint: Transferrin saturation at 12 weeks. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
iron polysaccharide complexiron sucrose
03
Conditions
iron deficiency anemia (IDA)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2000031166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031166.